Cargando…

Characterization of Monomeric Intermediates during VSV Glycoprotein Structural Transition

Entry of enveloped viruses requires fusion of viral and cellular membranes, driven by conformational changes of viral glycoproteins. Crystal structures provide static pictures of pre- and post-fusion conformations of these proteins but the transition pathway remains elusive. Here, using several biop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albertini, Aurélie A., Mérigoux, Cécile, Libersou, Sonia, Madiona, Karine, Bressanelli, Stéphane, Roche, Stéphane, Lepault, Jean, Melki, Ronald, Vachette, Patrice, Gaudin, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285605/ https://www.ncbi.nlm.nih.gov/pubmed/22383886 http://dx.doi.org/10.1371/journal.ppat.1002556

Ejemplares similares

Intermediate conformations during viral fusion glycoprotein structural transition
por: Baquero, Eduard, et al.
Publicado: (2013)

Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion
por: Libersou, Sonia, et al.
Publicado: (2010)

Structure and Working of Viral Fusion Machinery
por: Albertini, Aurélie, et al.
Publicado: (2011)

Monomeric Intermediates Formed by Vesiculovirus Glycoprotein during Its Low-pH-induced Structural Transition
por: Abou-Hamdan, Abbas, et al.
Publicado: (2018)

Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein
por: Nikolic, Jovan, et al.
Publicado: (2018)

Structure of the Low pH Conformation of Chandipura Virus G Reveals Important Features in the Evolution of the Vesiculovirus Glycoprotein
por: Baquero, Eduard, et al.
Publicado: (2015)

Crystal structure of Mokola virus glycoprotein in its post-fusion conformation
por: Belot, Laura, et al.
Publicado: (2020)

Structural and functional properties of prefibrillar α-synuclein oligomers
por: Pieri, Laura, et al.
Publicado: (2016)

Structural mapping techniques distinguish the surfaces of fibrillar 1N3R and 1N4R human tau
por: Caroux, Emilie, et al.
Publicado: (2021)

The 26S Proteasome Degrades the Soluble but Not the Fibrillar Form of the Yeast Prion Ure2p In Vitro
por: Wang, Kai, et al.
Publicado: (2015)

In vivo tmRNA protection by SmpB and pre-ribosome binding conformation in solution
por: Ranaei-Siadat, Ehsan, et al.
Publicado: (2014)

Negri bodies and other virus membrane-less replication compartments()
por: Nevers, Quentin, et al.
Publicado: (2020)

Recapitulating Trafficking of Nucleosides Into the Active Site of Polymerases of RNA Viruses: The Challenge and the Prize
por: Boulard, Yves, et al.
Publicado: (2021)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein
por: Kus, Nicole J., et al.
Publicado: (2018)

Dynamics and asymmetry in the dimer of the norovirus major capsid protein
por: Tubiana, Thibault, et al.
Publicado: (2017)

Hepatitis E virus RNA replication polyprotein: taking structural biology seriously
por: Fieulaine, Sonia, et al.
Publicado: (2023)

The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T Cells
por: Yu, Dongyang, et al.
Publicado: (2009)

Stability, structural and functional properties of a monomeric, calcium–loaded adenylate cyclase toxin, CyaA, from Bordetella pertussis
por: Cannella, Sara E., et al.
Publicado: (2017)

Molecular and Cellular Aspects of Rhabdovirus Entry
por: Albertini, Aurélie A. V., et al.
Publicado: (2012)

Model of a DNA-Protein Complex of the Architectural Monomeric Protein MC1 from Euryarchaea
por: Paquet, Françoise, et al.
Publicado: (2014)

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies
por: Logan, Nicola, et al.
Publicado: (2016)

Characterization of a Structural Intermediate of Flavivirus Membrane Fusion
por: Stiasny, Karin, et al.
Publicado: (2007)

Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G)
por: Chen, Yong, et al.
Publicado: (2009)

FAN1 Activity on Asymmetric Repair Intermediates Is Mediated by an Atypical Monomeric Virus-type Replication-Repair Nuclease Domain
por: Pennell, Simon, et al.
Publicado: (2014)

A mobile loop near the active site acts as a switch between the dual activities of a viral protease/deubiquitinase
por: Jupin, Isabelle, et al.
Publicado: (2017)

Murine GFP-Mx1 forms nuclear condensates and associates with cytoplasmic intermediate filaments: Novel antiviral activity against VSV
por: Sehgal, Pravin B., et al.
Publicado: (2021)

Rabies virus glycoprotein is a trimer
por: Gaudin, Yves, et al.
Publicado: (1992)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Autophagy-inducing peptides from mammalian VSV and fish VHSV rhabdoviral G glycoproteins (G) as models for the development of new therapeutic molecules
por: García-Valtanen, Pablo, et al.
Publicado: (2014)

Development and Applications of VSV Vectors Based on Cell Tropism
por: Tani, Hideki, et al.
Publicado: (2012)

Titration methods for rVSV-based vaccine manufacturing
por: Gélinas, Jean-François, et al.
Publicado: (2020)

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
por: Santoro, Francesco, et al.
Publicado: (2021)

Monomeric myosin anchoring
por: Wells, William A.
Publicado: (2004)

Engineering Monomeric Glycogenin
por: Dwek, David, et al.
Publicado: (2002)

Evaluation of a replication-competent VSV-SIV vaccine candidate
por: Jurgens, CK, et al.
Publicado: (2012)

Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles
por: Skinner, Amy M., et al.
Publicado: (2013)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
por: Kimpel, Janine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s9a2u8hj3pshse88c5t74efiea